Stay informed with the latest litigation news. Explore now

IP Verse

Glaxosmithkline competitive analysis

Latest publications and patents of Glaxosmithkline New

Explore the latest publications and patents granted to Glaxosmithkline, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Glaxosmithkline
EP4601988	Aug 20, 2025	Process For Production Of Aluminium Hydroxide Particles	Pending
EP4593875	Aug 6, 2025	Influenza Virus Vaccines	Pending
EP4593835	Aug 6, 2025	Gepotidacin For Use In The Treatment Of Bacterial Prostatitis	Pending
EP3829618	Jul 16, 2025	Antigen Purification Method	Granted
EP4577569	Jul 2, 2025	Antigen Binding Proteins And Uses Thereof	Pending
EP4577557	Jul 2, 2025	Rsv-F Proteins	Pending
EP4577556	Jul 2, 2025	Rsv-F Proteins	Pending
EP4387959	Jul 2, 2025	Preparation Of A P2X3 Antagonist	Pending
EP3389698	Jun 25, 2025	Dried Composition	Granted
EP3612550	Jun 18, 2025	Modified Cytomegalovirus Proteins And Stabilized Complexes	-

Latest oppositions filed by Glaxosmithkline

Explore patent oppositions filed by Glaxosmithkline against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3653221	Anti-Pvrig Antibodies And Methods Of Use	COMPUGEN	May 2, 2023
EP3590949	Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof	MODERNATX	Feb 17, 2023
EP3259597	Pvrig Polypeptides And Methods Of Treatment	COMPUGEN	Jan 5, 2023
EP3682905	Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof	MODERNATX	Aug 26, 2022
EP2970456	Methods And Compositions For Delivering Mrna Coded Antibodies	SHIRE HUMAN GENETIC THERAPIES	Feb 18, 2022
EP2997036	Purification Of Recombinantly Produced Polypeptides	MEDIMMUNE	Dec 3, 2021
EP3616720	Pharmaceutical Composition For Cancer Treatment	OSAKA UNIVERSITY	Nov 17, 2021
EP3137186	Methods For The Purification Of Proteins Using Caprylic Acid	NOVO NORDISK	Oct 26, 2021
EP3431485	Engineered Nucleic Acids And Methods Of Use Thereof	MODERNATX	Sep 30, 2021
EP3377618	Buffers For Stabilization Of Lentiviral Preparations	NOVARTIS	Aug 12, 2021

Latest patents of Glaxosmithkline opposed by its competitors

Explore Glaxosmithkline's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP4226941	Oct 23, 2024	Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna	5
EP3682884	Apr 24, 2024	Crystal Form Of Gsk1278863 And Preparation Method And Pharmaceutical Use Thereof	1
EP3480209	Nov 29, 2023	Expression System	1
EP3564378	Nov 1, 2023	Immunogenic Composition	1
EP3650019	Oct 11, 2023	Fluticasone Furoate In The Treatment Of Copd	3
EP4066819	Mar 1, 2023	Small Liposomes For Delivery Of Immunogen-Encoding Rna	4
EP4043040	Jan 11, 2023	Small Liposomes For Delivery Of Immunogen-Encoding Rna	4
EP4008357	Dec 28, 2022	Small Liposomes For Delivery Of Immunogen-Encoding Rna	4
EP4066855	Dec 28, 2022	Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna	4
EP4066857	Dec 21, 2022	Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna	4

Latest PTAB cases involving Glaxosmithkline New

Discover the latest PTAB cases involving Glaxosmithkline, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 15, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Glaxosmithkline
IPR2020-01577	Sep 4, 2020	EPIZYME	GLAXOSMITHKLINE	Terminated-Settled
IPR2020-00962	May 27, 2020	GLAXOSMITHKLINE	PFENEX	Terminated-Settled
IPR2020-00890	May 7, 2020	GLAXOSMITHKLINE	PFENEX	Terminated
IPR2020-00369	Jan 31, 2020	GLAXOSMITHKLINE CONSUMER HEALTHCARE	CIPLA	Institution Denied
IPR2020-00371	Jan 31, 2020	GLAXOSMITHKLINE CONSUMER HEALTHCARE	CIPLA	Institution Denied
IPR2020-00368	Jan 31, 2020	GLAXOSMITHKLINE CONSUMER HEALTHCARE	CIPLA	Institution Denied
IPR2020-00370	Jan 31, 2020	GLAXOSMITHKLINE CONSUMER HEALTHCARE	CIPLA	Institution Denied
IPR2020-00327	Dec 19, 2019	EPIZYME	GLAXOSMITHKLINE	Final Written Decision
IPR2020-00328	Dec 19, 2019	EPIZYME	GLAXOSMITHKLINE	Final Written Decision
IPR2019-01478	Aug 9, 2019	PFENEX	GLAXOSMITHKLINE	Institution Denied

Top competitors of Glaxosmithkline

Top competitors of Glaxosmithkline based on patent oppositions.

WEICKMANN & WEICKMANN

SANOFI

JG OPPOSITIONS